N
BNR

Nuveen’s Burning Rock Biotech BNR Stock Holding History

Nuveen’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,200
Closed -$124K – 3191
2022
Q3 		$124K Hold
5,200
– – ﹤0.01% 3144
2022
Q2 		$151K Hold
5,200
– – ﹤0.01% 3173
2022
Q1 		$483K Buy
5,200
+420
+9% +$36.5K ﹤0.01% 3027
2021
Q4 		$456K Sell
4,780
-2,660
-36% -$364K ﹤0.01% 3091
2021
Q3 		$1.33M Buy
7,440
+500
+7% +$111K ﹤0.01% 2864
2021
Q2 		$2.04M Buy
+6,940
New +$2.05M ﹤0.01% 2701

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Nuveen's BNR Position: Q4 2022 in Review

Nuveen sold out of Burning Rock Biotech (BNR) in Q4 2022, closing a stake of 5,200 shares — an estimated $124K sold.

Nuveen first reported a position in BNR in Q2 2021 and held it in 6 quarters. The position peaked at $2.04M in Q2 2021. 42 funds tracked by Wall St. Rank hold BNR as of Q4 2022.

  • Nuveen reported no remaining Burning Rock Biotech position as of Q4 2022 after selling out during the quarter.
  • Nuveen sold 5,200 Burning Rock Biotech shares in Q4 2022, an estimated $124K.
  • Nuveen first reported a position in Burning Rock Biotech in Q2 2021 and held it in 6 quarters.
  • Nuveen's Burning Rock Biotech position peaked at $2.04M in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2022.

Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.